Nachrichten zur Merck & Co Aktie

Merck: CHMP Recommends Against Approval Of Lagevrio For Treatment Of Certain Adults With COVID-19

KENILWORTH (NJ) (dpa-AFX) - Merck & Co Inc. (MRK) and Ridgeback Biotherapeutics said Friday that the Committee for Medicinal Products…

Merck: CHMP Recommends Against OK of Lagevrio for Certain Adults With Covid-19 >MRK

Merck: CHMP Recommends Against OK of Lagevrio for Certain Adults With Covid-19 >MRK...…

Merck and Ridgeback Biotherapeutics to appeal advisory panel to EU regulator’s decision to recommend refusing authorization of their COVID antiviral

Merck & Co. Inc. MRK and privately held Ridgeback Biotherapeutics said Friday a panel advising the European regulator has recommended…

NVIDIA-Aktie nach Zahlen im Aufwind - Fresenius will sich auf Kerngeschäft konzentrieren

Wien (www.aktiencheck.de) - Als Reaktion auf das Zahlenwerk von Mittwochabend konnte die Aktie von NVIDIA (ISIN: US67066G1040, WKN: 918422, Ticker-Symbol:…

Moderna stock pops after cancer-vaccine candidate gets FDA breakthrough designation

Moderna Inc. MRNAand Merck Inc. MRK shares increased in after-hours trading Wednesday after the pharmaceutical companies announced that a cancer-vaccine…

Lung Cancer Drugs Global Market Report 2023

NEW YORK, Feb. 21, 2023 /PRNewswire/ -- Major players in the lung cancer market are Bristol-Myers Squibb Company, Merck &…

Antiglaucoma Drugs Global Market Report 2023

NEW YORK, Feb. 20, 2023 /PRNewswire/ -- Major players in the antiglaucoma drugs market are Aerie Pharmaceuticals, Inc., Allergan, Novartis…

Is Most-Watched Stock Merck & Co., Inc. (MRK) Worth Betting on Now?

Zacks.com users have recently been watching Merck (MRK) quite a bit. Thus, it is worth knowing the facts that could…

Merck (MRK) Gets Priority Tag for Antiviral Drug Prevymis sNDA

The FDA grants priority review designation to Mercks (MRK) sNDA seeking expanded use of Prevymis. The PDUFA date is Jun…

Moderna fallen nach Studiendaten: Zinssorgen belasten US-Börsen

Die Inflationssorgen lassen die Anleger an der Wall Street zum Wochenschluss nicht los. Der Dow wird unter anderem vom Pharmakonzern…

FDA to Review Two Expansions of Mercks Prevymis >MRK

FDA to Review Two Expansions of Merck's Prevymis >MRK...…

Antiobesity Global Market Report 2023

NEW YORK, Feb. 16, 2023 /PRNewswire/ -- Major players in the anti-obesity market are F. Hoffmann-La Roche AG, GlaxoSmithKline PLC,…

Insiderhandel: President, Human Health Int?l verkauft Aktien von Merck & Company im Wert von 541.101$

Romanelli, Joseph - Vorstand - Tag der Transaktion: 2023-02-15...…

Insiderhandel: EVP, Chief HR Officer verkauft Aktien von Merck & Company im Wert von 198.017$

Mizell, Steven - Vorstand - Tag der Transaktion: 2023-02-13...…

DTP Vaccines Global Market Report 2023

NEW YORK, Feb. 13, 2023 /PRNewswire/ -- Major players in the DTP vaccines market are Merck & Co, Sanofi, GSK,…

Merck & Co: Die Konferenz des American College of Cardiology 2023 als ein wichtiger Katalysator? Aktienanalyse

Zürich (www.aktiencheck.de) - Merck & Co-Aktienanalyse von Analyst Trung Huynh von der Credit Suisse: Trung Huynh, Analyst von der Credit Suisse,…

Merck & Co: Solides Ergebnis, aber verhaltener Ausblick - Aktienanalyse

Wien (www.aktiencheck.de) - Merck & Co-Aktienanalyse von der Raiffeisen Bank International AG: Benedikt-Luka Antic, Analyst der Raiffeisen Bank International AG (RBI),…

Merck & Co: Kursziel angehoben

Charlotte, NC (www.aktiencheck.de) - Rating-Update: Robyn Karnauskas, Analystin von Truist, stuft die Aktie von Merck & Co Inc. (ISIN: US58933Y1055, WKN:…

Insiderhandel: EVP, Chief HR Officer verkauft Aktien von Merck & Company im Wert von 535.007$

Mizell, Steven - Vorstand - Tag der Transaktion: 2023-02-09...…

Merck & Co., Inc.: Merck: Women in Science? Absolutely.

NORTHAMPTON, MA / ACCESSWIRE / February 9, 2023 / Women scientists have historically been underrepresented in the field of process…

Aligos Therapeutics Announces Strategic Reprioritization of NASH and COVID-19 Programs and Confirms Key Timelines and Extension of Cash Runway to Year-End 2024

– Pipeline reprioritization emphasizes NASH and COVID-19 assets, ALG-055009 and ALG-097558, plus key ongoing collaborations, including the Merck & Co.…

Insiderhandel: EVP, Chief HR Officer verkauft Aktien von Merck & Company im Wert von 462.473$

Mizell, Steven - Vorstand - Tag der Transaktion: 2023-02-06...…

Wellmarker Bio Announces Clinical Trial Collaboration with MSD to evaluate WM-A1-3389 in combination with KEYTRUDA® (pembrolizumab)

Wellmarker Bio is pleased to sign a clinical collaboration and supply agreement with MSD (Merck & Co., Inc., Rahway, NJ,…

ROUNDUP: Merck & Co rechnet mit schwächerem Jahr - Aktie unter Druck

RAHWAY (dpa-AFX) - Der US-Pharmakonzern Merck & Co (Merck) dürfte nach kräftigen Zuwächsen im vergangenen Jahr den Rückwärtsgang einlegen. Der…

+++ Geschäftszahlen im Newsblog +++: Corona-Boom bei Merck & Co lässt nach – Ferrari erwartet kräftiges Gewinnplus

Corona-Boom bei Merck & Co lässt nach +++ Harley-Davidson verdient deutlich mehr +++ Shell erzielt Rekordgewinn +++ Die Geschäftszahlen…

Dow gibt Gewinne ab, Nasdaq 100 deutlich im Plus, Microsoft, Meta, Salesforce und Align Technology enorm stark, Merck & Co schwach – der Tag an der Wall Street

Gute Zahlen und ein überzeugender Ausblick von Meta haben am Donnerstag die Erholungsrally der US-Techwerte nochmals beschleunigt. Während die Meta-Aktien…

Merck & Co: Ausblick enttäuscht – Aktie rutscht ans Dow-Ende

Der US-Pharmakonzern Merck & Co dürfte nach kräftigen Zuwächsen im vergangenen Jahr den Rückwärtsgang einlegen. Der Vorstand kalkuliert auch wegen…

Merck (MRK) Q4 2022 Earnings Call Transcript

MRK earnings call for the period ending December 31, 2022....…

Merck (MRK) Beats on Q4 Earnings & Sales, 2023 View Disappoints

Merck (MRK) beats Q4 estimates for earnings and sales. Its 2023 profit guidance disappoints. Stock declines in pre-market....…

ROUNDUP: Merck & Co rechnet mit schwächerem Jahr - Aktie unter Druck

RAHWAY (dpa-AFX) - Der US-Pharmakonzern Merck & Co dürfte nach kräftigen Zuwächsen im vergangenen Jahr…

UPDATE 1-Merck forecasts sharp drop in COVID antiviral pill sales in 2023

... (Reuters) - Merck & Co on Thursday forecast a sharp decline in sales of its......…

Merck & Co: Ergebnis über Erwartungen, aber verhaltener Ausblick - Aktienanalyse

Wien (www.aktiencheck.de) - Merck & Co-Aktienanalyse von der Raiffeisen Bank International AG: Benedikt-Luka Antic, Analyst der Raiffeisen Bank International AG (RBI),…

Rückenwind durch Corona lässt nach: Merck & Co rechnet mit schwächerem Jahr

RAHWAY (dpa-AFX) - Der US-Pharmakonzern Merck & Co dürfte nach einem kräftigen Umsatz- und Gewinnanstieg…

Form 8-K Merck & Co., Inc. For: Feb 02

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Merck fourth quarter tops expectations on strong COVID pill sales

...By Michael Erman (Reuters) - Merck & Co on Thursday reported......…

Drug/Biotech Stocks Q4 Earnings Due on Feb 2: GILD, MRK & Others

Lets look at the four biotech/pharma companies slated to release quarterly results on Feb 2....…

Why Merck & Co. (MRK) Might Surprise This Earnings Season

Merck & Co. (MRK) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into…

Pharma Stock Roundup: JNJ Q4 Results Mixed, MRK Keytruda Prostate Cancer Study Ends

J&J (JNJ) reports mixed fourth-quarter results. Merck (MRK) discontinues an advanced prostate cancer study on blockbuster drug Keytruda for futility....…

Merck Animal Health: FDA Approves Expanded Indication For BRAVECTO Chews For Dogs

KENILWORTH (NJ) (dpa-AFX) - Merck Animal Health, a division of Merck & Co., Inc. (MRK), announced the U.S. Food and…

UPDATE 1-Merck ends Keytruda trial in prostate cancer patients after dismal interim data

... 25 (Reuters) - Merck & Co Inc said on Wednesday it was discontinuing......…

Merck Reports Keytruda Phase 3 Success, Failure >MRK

Merck Reports Keytruda Phase 3 Success, Failure >MRK...…

Merck (MRK) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, Merck (MRK) closed at $109.88, marking a -0.05% move from the previous day....…

Merck (MRK) Dips More Than Broader Markets: What You Should Know

Merck (MRK) closed at $110.45 in the latest trading session, marking a -1.6% move from the prior day....…

Merck set to remove cancer-causing chemical from top diabetes drugs - Bloomberg News

...(Reuters) - Merck & Co has discovered how its blockbuster..., Bloomberg News said. Merck did not immediately…

Pick Either Johnson & Johnson Stock Or Its Peer – Both May Offer Similar Returns

We believe that pharmaceutical giants Johnson & Johnson stock (NYSE: JNJ) and Merck stock (NYSE: MRK) will likely offer similar…

Insiderhandel: Exe V-P & Pres. MMD verkauft Aktien von Merck & Company im Wert von 9.431.915$

Chattopadhyay, Sanat - Vorstand - Tag der Transaktion: 2023-01-09...…

Merck To Complete Acquisition Of Imago

KENILWORTH (NJ) (dpa-AFX) - Merck (MRK) announced the successful completion of the cash tender offer, through a subsidiary, for all…

UPDATE 1-Merck to take legal action against unauthorized distributors of its COVID treatment in China

...(Adds details, background) SHANGHAI, Jan 11 (Reuters) - Merck & Co......…

Merck to take legal action against unauthorized distributors of its COVID treatment in China

...SHANGHAI, Jan 11 (Reuters) - Merck & Co said on Wednesday it would......…